Britain says G7 countries in health agreement for clinical trials boost


2/2

© Reuters. FILE PHOTO: Pfizer-BioNTech coronavirus disease (COVID-19) vaccines are seen at Sao Jose Hospital in Lisbon, Portugal, January 19, 2021. REUTERS/Pedro Nunes

2/2

LONDON (Reuters) – Britain said that the G7 group of advanced economies agreed on Friday to speed up and share results from clinical trials on, for instance, vaccines to better tackle the COVID-19 pandemic and future threats to global health.

The G7 Therapeutics and Vaccines Clinical Trials charter sets out shared principles to accelerate the speed with which clinical trials generate evidence to enable timely and decisive action on findings, said Britain’s health ministry.

“It contains a series of measures to make us all safer by improving clinical trials, quicker and wider access to safe vaccines, better use of data, more accurate health surveillance tools and greater collaboration between countries,” British health minister Matt Hancock said in a statement on Friday.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

READ  Scotland's Davidson girds for fight as support for independence rises





READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here